Author: Thiru

Here below is India’s intervention on ‘TRIPS plus IPR Enforcement’ as delivered at the WTO TRIPS Council on 9 June 2010.

On 4 June 2010, Dr. Margaret Chan (Director General, World Health Organization) announced Dr. Anne Marie Worning as ‘acting Director, Public Health, Innovation and Intellectual Property (PHI)’. According to the WHO website,

Dr Anne Marie Worning, a Danish national, is the Executive Director of the Director-General’s Office since April 2009.

Continue Reading →

The following WTO aerogram contains the agenda for the upcoming WTO Council for TRIPS meeting to be held in Geneva from 8 June 2010 to 9 June 2010. Paragraph 2 and agenda items l and m will be of interest to readers of this blog. It should be noted that in the original document, the text is capitalized.

WTO/AIR/3562/Rev. 1

1. The next meeting of the Council for TRIPS will be held in the Center William Rappard on 8-9 June 2010. The meeting will start at 11 A.M. Tuesday, 8 June.

Continue Reading →

The upcoming WTO Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS Council) meets on 8-9 June 2010 (next Tuesday and Wednesday); Martin Glass (Hong Kong) is the current chair of the TRIPS Council. Access to attend WTO TRIPS Council meetings is only granted to WTO Members and organizations with observer status to the TRIPS Council (such as the World Health Organization); consequently, non-governmental organizations (NGOs) are not permitted to observe the proceedings of the TRIPS Council. Continue Reading →

Open-ended consultations on copyright limitations and exceptions for persons with print disabilities
Geneva, May 27, 2010

Mr. Chairman,

Yesterday, during the first round of the consultations, Brazil recalled the reasons why there is an urgent need for a treaty on Improved Access for Blind, Visually Impaired and other Reading Disabled Persons. As civil society representatives were not present yesterday, I will recall some of the main points Brazil holds dear in these discussions.

Continue Reading →

On 19 May 2010, Global Health Progress (GHP) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) hosted a luncheon at the Vieux Bois in Geneva on the margins of the 63rd World Health Assembly for a targeted audience of over 90 persons including Ministers of Health, Ambassadors and senior officials from the Africa. Continue Reading →

Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines

Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty

Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30

I+A: Innovation+Access Continue Reading →

On Wednesday, 19 May 2010, the launch of the 2.3(c) Committee will take place at Room XXV of the Palais de Nations from 13:00 to 14:30. Element 2.3(c) of the WHO Global Strategy on Public Health, Innovation and Intellectual Property states:

encourage further exploratory discussions on the utility of possible instruments or mechanisms for essential health and biomedical R&D, including inter alia, an essential health and biomedical R&D treaty

Continue Reading →